Is frusemide (furosemide) safe to use during the second trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Furosemide Should Generally Be Avoided in the Second Trimester of Pregnancy

Furosemide is not considered safe for routine use during the second trimester of pregnancy and should only be used if the potential benefit clearly justifies the substantial fetal and maternal risks. The FDA drug label explicitly states that furosemide caused unexplained maternal deaths and abortions in animal studies at doses as low as 2 times the maximum human dose, and there are no adequate well-controlled studies in pregnant women 1.

Critical Safety Concerns

Fetal Risks

The FDA labeling documents severe reproductive toxicity:

  • Maternal deaths and abortions occurred in rabbits at 25-100 mg/kg (2-8 times human doses) specifically when administered during Days 12-17 of gestation (equivalent to second trimester) 1
  • Fetal hydronephrosis (kidney distention) was observed in multiple animal studies 1
  • Fetal lethality can precede maternal deaths 1

Mechanism of Harm

Furosemide crosses the placenta and can:

  • Reduce uteroplacental perfusion by decreasing maternal blood volume
  • Potentially compromise fetal kidney development
  • Cause electrolyte disturbances that affect both mother and fetus

When Furosemide Might Be Considered

The 2020 ESC position paper addresses diuretics in pregnancy primarily for acute severe complications 2:

Acceptable scenarios (with intensive monitoring):

  • Acute pulmonary edema in pre-eclampsia (use IV nitroglycerin as first choice, not furosemide) 2
  • Severe heart failure with maternal hemodynamic compromise where delivery is not immediately feasible 2
  • Life-threatening volume overload unresponsive to safer alternatives

The clinical trial evidence is limited but concerning:

  • One small pilot study (n=21 per group) found furosemide 20 mg daily had similar outcomes to amlodipine and aspirin for chronic hypertension, but this was underpowered to detect rare serious adverse events 3
  • A hemodynamic study showed furosemide decreased cardiac output and stroke volume while increasing peripheral resistance—potentially harmful changes that "did not approach expected mean for pregnancy" 4

Preferred Alternatives for Common Indications

For Hypertension in Pregnancy

The 2011 ESC guidelines clearly state 5:

  • First-line agents: Alpha-methyldopa (safest with 7.5-year infant follow-up data) or labetalol
  • Alternative: Metoprolol
  • Strictly contraindicated: ACE inhibitors, ARBs, direct renin inhibitors
  • Not recommended: Routine diuretics for blood pressure control

For Edema in Pregnancy

  • Physiologic edema is normal and does not require treatment
  • Non-pharmacological management: left lateral positioning, activity limitation, normal salt diet 5
  • Diuretics should NOT be used for routine pregnancy edema

For Severe Hypertensive Emergency

If BP >160/100 mmHg 2:

  • IV labetalol (10-20 mg boluses)
  • IV hydralazine (5-10 mg doses, though more adverse effects)
  • Oral nifedipine immediate-release (only if IV access unavailable, 10-20 mg)

Critical Monitoring If Furosemide Must Be Used

Based on the FDA label and research evidence 1, 6:

  • Intensive electrolyte monitoring (furosemide causes more pronounced electrolyte losses in pregnancy) 6
  • Serial fetal growth assessments (potential for higher birth weights paradoxically, or growth restriction from reduced perfusion) 1
  • Renal function monitoring in both mother and fetus
  • Lowest effective dose for shortest duration possible
  • Immediate discontinuation if any signs of fetal compromise

Common Pitfalls to Avoid

  1. Do not use furosemide for routine pregnancy-related edema—this is physiologic and treatment may harm uteroplacental perfusion
  2. Do not continue pre-pregnancy furosemide automatically—reassess indication and switch to safer alternatives when possible
  3. Do not assume oral furosemide efficacy—intestinal edema in pregnancy reduces absorption 7
  4. Do not neglect electrolyte monitoring—pregnancy amplifies furosemide's electrolyte effects 6

Bottom Line Algorithm

Is there life-threatening maternal pulmonary edema or heart failure?

  • Yes → Consider furosemide with intensive monitoring OR prefer IV nitroglycerin for pulmonary edema 2
  • No → Do NOT use furosemide

Is this for hypertension control?

  • Use methyldopa or labetalol instead 5

Is this for routine edema?

  • No pharmacologic treatment needed; use positioning and rest 5

The evidence consistently points toward furosemide being a high-risk medication in the second trimester that should be reserved only for situations where maternal survival is threatened and safer alternatives have failed.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.